Table 2 Participants’ preferences for headache treatment by primary headache disorder
From: Patients’ preferences for headache acute and preventive treatment
Episodic | Chronic | Tension-Type | Episodic | Chronic | Cluster | Episodic | Chronic | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
All | Migraine | Migraine | Migraine | Headache (TTH) | TTH | TTH | Headache (CH) | CH | CH | ||
Q No | Question | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) |
Symptomatic treatment | |||||||||||
Q4 | More important is: | ||||||||||
Safety | 88 (17.1) | 60 (16.1) | 38 (17.3) | 22 (14.5) | 22 (20.8) | 7 (28.0) | 15 (18.5) | 6 (17.1) | 4 (28.6) | 2 (9.5) | |
Efficacy | 416 (80.9) | 308 (82.8) | 180 (81.8) | 128 (84.2) | 81 (76.4) | 17 (68.0) | 64 (79.0) | 27 (77.1) | 10 (71.4) | 17 (81.0) | |
Route of administration | 9 (1.8) | 4 (1.1) | 2 (0.9) | 2 (1.3) | 3 (2.8) | 1 (4.0) | 2 (2.5) | 2 (5.7) | 0 | 2 (9.5) | |
Q5 | They prefer to take: | ||||||||||
A pill | 452 (88.1) | 327 (87.9) | 190 (86.4) | 137 (90.1) | 95 (89.6) | 21 (84.0) | 74 (91.4) | 30 (85.7) | 10 (71.4) | 20 (95.2) | |
A suppository | 17 (3.3) | 14 (3.8) | 10 (4.5) | 4 (2.6) | 2 (1.9) | 0 | 2 (2.5) | 1 (2.9) | 0 | 1 (4.8) | |
A nasal sprey | 27 (5.3) | 18 (4.8) | 14 (6.4) | 4 (2.6) | 5 (4.7) | 4 (16.0) | 1 (1.2) | 4 (11.4) | 4 (28.6) | 0 | |
sc injection | 4 (0.8) | 4 (1.1) | 2 (0.9) | 2 (1.3) | 0 | 0 | 0 | 0 | 0 | 0 | |
Im injection | 9 (1.8) | 5 (1.3) | 3 (1.4) | 2 (1.3) | 4 (3.8) | 0 | 4 (4.9) | 0 | 0 | 0 | |
iv injection | 4 (0.8) | 4 (1.1) | 1 (0.5) | 3 (2.0) | 0 | 0 | 0 | 0 | 0 | 0 | |
Q6 | They do not want to take: | ||||||||||
Pill | 11 (2.2) | 6 (1.6) | 6 (2.7) | 0 | 4 (3.8) | 0 | 4 (4.9) | 1 (2.9) | 1 (7.1) | 0 | |
Suppository | 148 (29.0) | 102 (27.6) | 53 (24.1) | 49 (32.7) | 37 (34.9) | 8 (32.0) | 29 (35.8) | 9 (25.7) | 3 (21.4) | 6 (28.6) | |
Nasal sprey | 35 (6.8) | 30 (8.1) | 14 (6.4) | 16 (10.7) | 3 (2.8) | 0 | 3 (3.7) | 2 (5.7) | 0 | 2 (9.5) | |
sc injection | 18 (3.5) | 12 (3.2) | 11 (5.0) | 1 (0.7) | 3 (2.8) | 3 (12.0) | 0 | 3 (8.6) | 1 (7.1) | 2 (9.5) | |
Im injection | 70 (13.7) | 54 (14.6) | 35 (15.9) | 19 (12.7) | 13 (12.3) | 3 (12.0) | 10 (12.3) | 3 (8.6) | 1 (7.1) | 2 (9.5) | |
iv injection | 229 (44.8) | 166 (44.9) | 101 (45.9) | 65 43.3) | 46 (43.4) | 11 (44.0) | 35 (43.2) | 17 (48.6) | 8 (57.1) | 9 (42.9) | |
Q7 | They prefer more: | ||||||||||
Drugs | 168 (32.7) | 120 (32.3) | 83 (37.7) | 37 (24.5) | 37 (34.6) | 7 (28.0) | 30 (36.6) | 11 (31.4) | 5 (35.7) | 6 (28.6) | |
A device | 345 (67.3) | 251 (67.7) | 137 (62.3) | 114 (75.5) | 70 (65.4) | 18 (72.0) | 52 (63.4) | 24 (68.6) | 9 (4.3) | 15 (71.4) | |
Preventive treatment | |||||||||||
Q8 | More important is: | ||||||||||
Safety | 124 (24.1) | 86 (23.1) | 53 (24.1) | 33 (21.7) | 30 (28.0) | 8 (32.0) | 22 (26.8) | 8 (22.9) | 6 (42.9) | 2 (9.5) | |
Efficacy | 372 (72.4) | 271 (72.8) | 158 (71.8) | 113 (74.3) | 74 (69.2) | 16 (64.0) | 58 (70.7) | 27 (77.1) | 8 (57.1) | 19 (90.5) | |
Route of administration | 18 (3.5) | 15 (4.0) | 9 (4.1) | 6 (3.9) | 3 (2.80 | 1 (4.0) | 2 (2.4) | 0 | 0 | 0 | |
Q9 | They prefer to take: | ||||||||||
1 pill/day | 275 (53.8) | 189 (51.1) | 122 (55.5) | 67 (44.7) | 67 (63.2) | 16 (64.0) | 51 (63.0) | 19 (54.3) | 7 (50.0) | 12 (57.1) | |
2 pills/ day | 39 (7.6) | 27 (7.3) | 18 (8.2) | 9 (6.0) | 9 (8.5) | 4 (16.0) | 5 (6.2) | 3 (8.6) | 2 (14.3) | 1 (4.8) | |
3 pills/day | 10 (2.0) | 8 (2.2) | 6 (2.7) | 2 (1.3) | 0 | 0 | 0 | 2 (5.7) | 0 | 2 (9.5) | |
sc injection/ month | 41 (8.0) | 30 (8.1) | 22 (10.0) | 8 (5.3) | 9 (8.5) | 2 (8.0) | 7 (8.6) | 2 (5.7) | 0 | 2 (9.5) | |
iv injection/ month | 16 (3.1) | 14 (3.8) | 9 (4.1) | 5 (3.3) | 1 (0.9) | 0 | 1 (1.2) | 1 (2.9) | 1 (7.1) | 0 | |
sc injection/ 3 month | 68 (13.3) | 55 (14.9) | 27 (12.3) | 28 (18.7) | 9 (8.5) | 0 | 9 (11.1) | 4 (11.4) | 2 (14.3) | 2 (9.5) | |
iv injection/ 3 month | 62 (12.1) | 47 (12.7) | 16 (7.3) | 31 (20.7) | 11 (10.4) | 3 (12.0) | 8 (9.9) | 4 (11.4) | 2 (14.3) | 2 (9.5) | |
Q10 | They do not want to take: | ||||||||||
1 pill/day | 5 (1.0) | 3 (0.8) | 3 (1.4) | 0 | 2 (1.9) | 0 | 2 (2.5) | 0 | 0 | 0 | |
2 pills/ day | 7 (1.4) | 5 (1.4) | 4 (1.8) | 1 (0.7) | 2 (1.9) | 1 (4.0) | 1 (1.2) | 0 | 0 | 0 | |
3 pills/day | 163 (32.0) | 122 (33.1) | 60 (27.3) | 62 (41.6) | 32 (30.2) | 8 (32.0) | 24 (29.6) | 9 (25.7) | 3 (21.4) | 6 (28.6) | |
sc injection/ month | 67 (13.1) | 44 (11.9) | 26 (1.8) | 18 (12.1) | 18 (17.0) | 3 (12.0) | 15 (18.5) | 5 (14.3) | 2 (14.3) | 3 (14.3) | |
iv injection/ month | 196 (38.4) | 146 (39.6) | 101 (45.9) | 45 (30.2) | 42 (39.6) | 11 (44.0) | 31 (38.3) | 8 (22.9) | 3 (21.4) | 5 (23.8) | |
sc injection/ 3 month | 15 (2.9) | 9 (2.4) | 5 (2.3) | 4 (2.7) | 1 (0.9) | 0 | 1 (1.2) | 5 (14.3) | 2 (14.3) | 3 (14.3) | |
iv injection/ 3 month | 57 (11.2) | 40 (10.8) | 21 (9.5) | 19 (12.8) | 9 (8.5) | 2 (8.0) | 7 (8.6) | 8 (22.9) | 4 (28.6) | 4 (19.0) | |
Q11 | They prefer more: | ||||||||||
Drugs | 189 (36.9) | 136 (36.7) | 96 (43.6) | 40 (26.5) | 43 (40.6) | 8 (32.0) | 35 (43.2) | 10 (28.6) | 3 (21.4) | 7 (33.3) | |
A device | 323 (63.1) | 235 (63.3) | 124 (56.4) | 111 (73.5) | 63 (59.4) | 17 (68.0) | 46 (56.8) | 25 (71.4) | 11 (78.6) | 14 (66.7) | |